Deoxyhypusine Hydroxylase from Plasmodium vivax, the Neglected Human Malaria Parasite: Molecular Cloning, Expression and Specific Inhibition by the 5-LOX Inhibitor Zileuton

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Atemnkeng, Veronika Anyigoh ^a   Pink, Mario ^a   Schmitz Spanke, Simone ^a   Wu, Xian Jun ^b   Dong, Liang Liang ^b   Zhao, Kai Hong ^b   May, Caroline ^c   Laufer, Stefan ^d   Langer, Barbara ^a   Kaiser, Annette ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYHYPUSINE HYDROXYLASE; HISTIDINE; LYASE; OXYGENASE; PHYCOCYANIN LYASE; UNCLASSIFIED DRUG; ZILEUTON;

ARTICLE; CONTROLLED STUDY; DEOXYHYPUSINE HYDROXYLASE GENE; DRUG DETERMINATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBUNIT; ESCHERICHIA COLI; GENE; GENE SEQUENCE; HUMAN; HUMAN CELL; MASS FRAGMENTOGRAPHY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; ORTHOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PLASMODIUM YOELII; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CLONING, MOLECULAR; CLUSTER ANALYSIS; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; HYDROXYUREA; LIPOXYGENASE INHIBITORS; MALARIA, VIVAX; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; PHYCOCYANIN; PLASMODIUM VIVAX; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC;

EID: 84874670261     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058318     Document Type: Article

References (40)

1. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, et al. (2007) Vivax Malaria: Neglected and Not Benign. Am J Trop Med Hyg. 77: 79-87.
2. Krotoski WA, (1989) The hypnozoite and malarial relapse. Prog Clin Parasitol. 1: 1-19.
3. Baird JK, Hoffman SL, (2004) Primaquine therapy for malaria. Clin Infect Dis 39: 1336-1345.
4. Price RN, Douglas NM, Anstey NM, (2009) New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis 22: 430-435.
5. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, et al. (2008) Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 455: 757-763.
6. Sattabongkot J, Yimamnuaychoke N, Leelaudomlipi S, Rasameesoraj M, Jenwithisuk R, et al. (2006) Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg. 74: 708-715.
7. Price RN, Douglas NM, Anstey NM, von Seidlein L, (2011) Plasmodium vivax treatments: what are we looking for? Curr Opin Infec Dis 24: 578-585.
8. Park MH, Nishimura K, Zanelli CF, Valentini CR, (2011) Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids 38(2): 491-500.
9. Saini P, Eyler DE, Green R, Dever TE, (2009) Hypusine-containing protein eIF5A promotes translation elongation. Nature 459: 118-121.
10. Scuoppo C, Miething C, Lindqvist L, Reyes J, Ruse C, et al. (2011) A tumour suppressor network relying on the polyamine-hypusine axis. Nature 487(7406): 244-248.
11. Frommholz D, Kusch P, Blavid R, Scheer H, Tu JM, et al. (2009) Completing the hypusine pathway in Plasmodium. FEBS J 276: 5881-5891.
12. Scheer H, Zhao KH, (2008) Biliprotein maturation: the chromophore attachment. Mol Microbiol 68: 263-276.
13. Park JH, Aravind L, Wolff EC, Kaevel J, Kim YS, et al. (2006) Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme. Proc Natl Acad Sci U S A 310: 51-56.
14. Dong Z, Arnold RJ, Yang Y, Park MH, Hrncirova P, et al. (2005) Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis. Mol Cell Proteomics 4: 993-1001.
15. Kerscher B, Nzukou E, Kaiser A, (2010) Assessment of deoxyhypusine hydroxylase as a putative, novel drug target. Amino Acids 38: 471-477.
16. Rossi A, Pergola C, Koeberle A, Hoffmann M, Dehm F, (2010) The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Br J Pharmacol 161: 555-570.
17. Aparoy P, Reddy RN, Guruprasad L, Reddy MR, Reddanna P, (2008) Homology modeling of 5-lipoxygenase and hints for better inhibitor design. J Comput. Aided Mol. Des. 22: 611-619.
18. Gilbert NC, Bartlett SG, Waight MT, Neau DB, Boeglin WE, (2011) The structure of human 5-lipoxygenase. Science 14: 217-219.
19. Chawla B, Kumar RR, Tyagi N, Subramanian G, Srinivasan N, et al. (2012) A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani. PLoS 7(3): e33138. Epub 2012 Mar 16.
20. Udomsangpetch R, Somsri S, Panichakul T, Chotivanich K, Sirichaisinthop J, et al. (2007) Short-term in vitro culture of field isolates of Plasmodium vivax using umbilical cord blood. Parasitol Int. 56: 65-69.
21. Ribaut C, Berry A, Chevalley S, Reybier K, Morlais I, et al. (2008) Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species. Malaria J 5: 45.
22. Njuguna JT, Nassar M, Hoerauf A, Kaiser AE, (2006) Cloning, expression and functional activity of deoxyhypusine synthase from Plasmodium vivax. BMC Microbiol. 16 6: 91.
23. Sasaki K, Abid MR, Miyazaki M, (1996) Deoxyhypusine synthase gene is essential for cell viability in the yeast Saccharomyces cerevisiae. FEBS Lett 384: 151-154.
24. Blot N, Wu XJ, Thomas JC, Zhang J, Garczarek L, et al. (2009) Phycourobilin in trichromatic phycocyanin from oceanic cyanobacteria is formed post-translationally by a phycoerythrobilin lyase-isomerase. 284: 9290-9298.
25. Pain A, Böhme U, Berry AE, Mungall K, Finn RD, et al. (2008) The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature 455: 799-803.
26. Zhao KH, Zhu JP, Song B, Zhou M, Storf M, et al. (2004) Non-enzymatic chromophore attachment in biliproteins: Conformational control by the detergent Triton X-100. Biochim Biophys Acta 1657: 131-145.
27. Gonzales EB, Kawate T, Gouaux E, (2009) Architecture and ion sites in acid-sensing ion channels and P2X receptors. Nature 460: 599-604.
28. Zhao K, Liu M, Burgess RR, (2005) The global transcriptional response of Escherichia coli to induced sigma 32 protein involves sigma 32 regulon activation followed by inactivation and degradation of sigma 32 in vivo. J Biol Chem 280: 17758-17768.
29. Zhao KH, Su P, Tu JM, Wang X, Liu H, (2008) Phycobilin:cystein-84 biliprotein lyase, a near-universal lyase for cysteine-84-binding sites in cyanobacterial phycobiliproteins. Proc Natl Acad Sci U S A. 104: 14300-14305.
30. Kippert F, Gerloff DL, (2008) Highly Sensitive Detection of Individual HEAT and ARM Repeats with HHpred and COACH. PLOS One 4: 1-14.
31. Foth BJ, McFadden GI, (2003) The apicoplast: a plastid in Plasmodium falciparum and other Apicomplexan parasites. Int Rev Cytol 224: 57-110.
32. Lee BC, Hill P, (1992) Identification of an outer-membrane haemoglobin-binding protein in Neisseria meningitides. J Gen Microbiol 138: 2647-2656.
33. Istvan ES, Dharia NV, Bopp SE, Gluzman I, Winzeler EA, et al. (2011) Validation of isoleucine utilization targets in Plasmodium falciparum. Proc Natl Acad Sci U S A. 25: 1627-1632.
34. Sievert H, Venz S, Platas-Barradas O, Dhople VM, Schaletzky M, et al. (2012) Protein-Protein-Interaction Network Organization of the Hypusine Modification System. Mol Cell Proteomics. Epup Aug 10.
35. Kubavat AH, Khippal N, Tak S, Rijhwani P, Bhargava S (2012) A Randomized, Comparative, Multicentric Clinical Trial to Assess the Efficacy and Safety of Zileuton Extended-Release Tablets With Montelukast Sodium Tablets in Patients Suffering From Chronic Persistent Asthma. Am J Ther. 23 [Epub ahead of print].
36. Wu Y, He C, Gao Y, He S, Liu Y, (2012) Dynamic modeling of human 5-lipoxygenase-inhibitor interactions helps to discover novel inhibitors. J Med Chem 22: 2597-2605.
37. Miranda de SA, Brant F, Machado FS, Rachid MA, Teixera AL, (2011) Improving cognitive outcome in cerebral malaria: Insights from Clinical and Experimental Research. Cent Nerv Syst Agents Med Chem 11: 285-295.
38. Kupka M, Zhang J, Fu WL, Tu JM, Böhm S, et al. (2009) Catalytic mechanism of S-type phycobiliprotein lyase: chaperone-like action and functional amino acid residues. J Biol Chem 284: 36405-36414.
39. Cole C, Barber JD, Barton GJ (2008) Nucl Acids Res 35 (suppl. 2) W197-W201 [link].
40. Kaiser A, Ulmer D, Goebel T, Holzgrabe U, Saeftel M, et al. (2006) Inhibition of hypusine biosynthesis in plasmodium: a possible, new strategy in prevention and therapy of malaria. Mini Rev Med Chem. (11): 1231-1241.